medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2017, Number 2

<< Back Next >>

Ann Hepatol 2017; 16 (2)

Age-Standardized Mortality Rates Related to Cirrhosis in Brazil from 2000 to 2012: A Nationwide Analysis

Perazzo H, Pacheco AG, De Boni R, Luz PM, Fittipaldi J, Cardoso SW, Grinsztejn B, Veloso VG

Language: English
References: 32
Page: 269-278
PDF size: 168.07 Kb.


ABSTRACT

Background. Cirrhosis remains the most frequent liver-related cause of death worldwide and we aimed to evaluate its burden in Brazil from 2000 to 2012. Material and methods. The Brazilian National Death Registry was analyzed from 2000 to 2012. Death by cirrhosis was defined by the presence of I85, K73 and/or K74 ICD-10 codes in contributing or underlying causes of death on the death certificate (DC). Crude mortality rates were calculated as the ratio of the absolute number of deaths and the estimated population. Mortality rates were age-adjusted by the direct standardization method using the WHO standard population. Results. A total of 265,180 deaths where cirrhosis was mentioned on the DC [77% male, aged 56 years] occurred from 2000 to 2012. Cirrhosis codes were present in 46% of liver-related deaths and 2% of all deaths in this period. Despite an increase in the absolute number of deaths (n = 18,245 to 22,340), the age-standardized mortality rates (95%CI) decreased from 13.32 (13.16-13.48) to 11.71 (11.59-11.83) per 100,000 inhabitants from 2000 to 2012 (p ‹ 0.001). This trend was not uniform across the country, with decreases in death rates in the South [14.46 (14.07-14.87) to 10.89 (10.59-11.19)] and Southeast [15.85 (15.6-16.09) to 12.52 (12.34-12.70)] and increases in the North [8.84 (8.24-9.43) to 11.53 (11.08-11.99)] and Northeast [9.41 (9.13-9.69) to 10.93 (10.68-11.17)] (p ‹ 0.001 for all). Conclusion. Cirrhosis remains a major public health issue, despite the reduction in mortality rates in the last decade.


REFERENCES

  1. Heffler S, Levit K, Smith S, Smith C, Cowan C, Lazenby H, Freeland M. Health spending growth up in 1999; faster growth expected in the future. Health Aff (Millwood) 2001; 20: 193-203.

  2. Innes H, Goldberg D, Dillon J, Hutchinson SJ. Strategies for the treatment of Hepatitis C in an era of interferon-free therapies: what public health outcomes do we value most? Gut 2015; 64: 1800-9.

  3. Vong S, Bell BP. Chronic liver disease mortality in the United States, 1990-1998. Hepatology 2004; 39: 476-83.

  4. Asrani SK, Larson JJ, Yawn B, Therneau TM, Kim WR. Underestimation of liver-related mortality in the United States. Gastroenterology 2013; 145: 375-82.

  5. Blachier M, Leleu H, Peck-Radosavljevic M, Valla DC, Roudot- Thoraval F. The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol 2013; 58: 593-608.

  6. Mendez-Sanchez N, Villa AR, Chavez-Tapia NC, Ponciano- Rodriguez G, Almeda-Valdes P, Gonzalez D, Uribe M. Trends in liver disease prevalence in Mexico from 2005 to 2050 through mortality data. Ann Hepatol 2005; 4: 52-5.

  7. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2095-128.

  8. Scaglione S, Kliethermes S, Cao G, Shoham D, Durazo R, Luke A, Volk ML. The Epidemiology of Cirrhosis in the United States: A Population-based Study. J Clin Gastroenterol 2015; 49: 690-6.

  9. Brasil. Guideline for information of cause of death in the death certificate [Manual de instruções para o preenchimento da declaração de obito]. [cited 25 March 2015; Available at: http://svs.aids.gov.br/download/manuais/ Manual_Instr_ Preench_DO_2011_jan.pdf] Brasilia: Brazilian Ministry of Health [Ministerio da Saude do Brasil]; Brazil; 2001.

  10. Kulhanova I, Menvielle G, Bopp M, Borrell C, Deboosere P, Eikemo TA, Hoffmann R, et al. Socioeconomic differences in the use of ill-defined causes of death in 16 European countries. BMC Public Health 2014; 14: 1295.

  11. Lima EE, Queiroz BL. Evolution of the deaths registry system in Brazil: associations with changes in the mortality profile, under-registration of death counts, and ill-defined causes of death. Cad Saude Publica 2014; 30: 1721-30.

  12. Smith P. Comparison between Registries: Age standardised rates. In: Cancer Incidence in Five Continents. Vol. V. Lyon, France: International Agency for Research on Cancer; 1987.

  13. Breslow NE, Day NE. Rates and Rate Standardization. In: Statistical Methods in Cancer Research. Vol. II. Lyon, France: International Agency for Research on Cancer; 1987.

  14. Ahmad OB, Boschi-Pinto C, Lopez AD, Murray CJ, Lozano R, Inoue M. Age-standardization of rates: a new WHO standard. GPE Discussion Paper Series: N° 31: World Health Organization, 2001. [cited 25 March 2015; Available from www.who.int/healthinfo/paper31.pdf].

  15. WHO. WHO World Standard population (2000-2025) 2014 [cited 25 March 2015; Available from: http://seer.cancer.gov/ stdpopulations /world.who.html

  16. Dalmau-Bueno A, Garcia-Altes A, Mari-Dell'olmo M, Perez K, Espelt A, Kunst AE, Borrell C. Trends in socioeconomic inequalities in cirrhosis mortality in an urban area of Southern Europe: a multilevel approach. J Epidemiol Community Health 2010; 64: 720-7.

  17. Mokdad AA, Lopez AD, Shahraz S, Lozano R, Mokdad AH, Stanaway J, Murray CJ, et al. Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis. BMC Med 2014; 12: 145.

  18. Zatonski WA, Sulkowska U, Manczuk M, Rehm J, Boffetta P, Lowenfels AB, La Vecchia C. Liver cirrhosis mortality in Europe, with special attention to Central and Eastern Europe. Eur Addict Res 2010; 16: 193-201.

  19. Marinho RT, Duarte H, Giria J, Nunes J, Ferreira A, Velosa J. The burden of alcoholism in fifteen years of cirrhosis hospital admissions in Portugal. Liver Int 2015; 35: 746-55.

  20. Mendez-Sanchez N, Garcia-Villegas E, Merino-Zeferino B, Ochoa-Cruz S, Villa AR, Madrigal H, Kobashi-Margain RA, et al. Liver diseases in Mexico and their associated mortality trends from 2000 to 2007: A retrospective study of the nation and the federal states. Ann Hepatol 2010; 9: 428-38.

  21. Nader LA, de Mattos AA, Bastos GA. Burden of liver disease in Brazil. Liver Int 2014; 34: 844-9.

  22. Anderson P, Chisholm D, Fuhr DC. Effectiveness and costeffectiveness of policies and programmes to reduce the harm caused by alcohol. Lancet 2009; 373: 2234-46.

  23. Spearman CW, Sonderup MW. Health disparities in liver disease in Sub-Saharan Africa. Liver Int 2015; 35: 2063-71.

  24. Chapmann & Hall. Medical Biostatistics, 3rd ed. CRCBiostatistics Series; 2012.

  25. Franca E, Campos D, Guimaraes MD, Souza MF. Use of verbal autopsy in a national health information system: Effects of the investigation of ill-defined causes of death on proportional mortality due to injury in small municipalities in Brazil. Popul Health Metr 2011; 9: 39.

  26. Marchand JL, Imbernon E, Goldberg M. [Causes of death in a cohort of EDF-GDF employees: comparison between occupational medicine and official statistics data]. Rev Epidemiol Sante Publique 2003; 51: 469-80.

  27. de Lima EE, Queiroz BL. Evolution of the deaths registry system in Brazil: associations with changes in the mortality profile, under-registration of death counts, and ill-defined causes of death. Cad Saude Publica 2014; 30: 1721-30.

  28. França E, de Abreu DX, Rao C, Lopez AD. Evaluation of cause-of-death statistics for Brazil, 2002-2004. Int J Epidemiol 2008; 37: 891-901.

  29. França E, da Cunha CC, Vasconcelos AM, Escalante JJ, de Abreu DX, de Lima RB, de Morais Neto OL. Investigation of ill-defined causes of death: assessment of a program's performance in a state from the Northeastern region of Brazil. Rev Bras Epidemiol 2014; 17: 119-34.

  30. França E, Teixeira R, Ishitani L, Duncan BB, Cortez-Escalante JJ, Morais Neto OL, Szwarcwald CL. Ill-defined causes of death in Brazil: a redistribution method based on the investigation of such causes. Rev Saude Publica 2014; 48: 671-81.

  31. Brasil. Guideline for investigation of ill-defined causes of death [Manual para investigação do obito com causa mal definida]. [cited 25 March 2015; Available at: http://svs. aids.gov.br/download/manuais/manual_obito_mal_ definida.pdf] Brasilia (DF): Brazilian Ministry of Health [Ministério da Saude do Brasil]; Brazil; 2009.

  32. Sheron N. Alcohol and liver disease in Europe - Simple measures have the potential to prevent tens of thousands of premature deaths. J Hepatol 2016; 64: 957-67.




2020     |     www.medigraphic.com